Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical Pathways

Bogdan-Petru Tichil, Anamaria Besleaga, Mihaela Laura Vica, Adrian Florea

Open source

DOI
10.20944/preprints202605.1807.v1
Published
2026-05-26
Container
Not recorded
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.20944/preprints202605.1807.v1,
  title = {Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical Pathways},
  author = {Bogdan-Petru Tichil and Anamaria Besleaga and Mihaela Laura Vica and Adrian Florea},
  year = {2026},
  doi = {10.20944/preprints202605.1807.v1},
  url = {https://doi.org/10.20944/preprints202605.1807.v1}
}

RIS

TY  - JOUR
TI  - Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical Pathways
AU  - Bogdan-Petru Tichil
AU  - Anamaria Besleaga
AU  - Mihaela Laura Vica
AU  - Adrian Florea
PY  - 2026
DO  - 10.20944/preprints202605.1807.v1
UR  - https://doi.org/10.20944/preprints202605.1807.v1
ER  - 

APA

Tichil, B., Besleaga, A., Vica, M. L., & Florea, A. (2026). Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical Pathways. https://doi.org/10.20944/preprints202605.1807.v1

Source records